Truist has initiated coverage of Larimar Therapeutics (NASDAQ:LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory updates for its drug candidate nomla for Friedreich’s ...

Adam Sperling has been named the new executive director for the Truist Championship. His role starts Feb. 3 and he'll oversee ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...

This was the stock's second consecutive day of gains.

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...

Truist Financial on Friday exceeded Wall Street estimates for fourth-quarter profit, helped by stronger investment banking ...

Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.

As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...

Truist initiated coverage of Tronox (TROX) with a Buy rating and $17 price target The firm believes Tronox has one of the “strongest ...

Mo Ramani replaces Darrin Benhart, who will move into a newly created role as Key’s chief regulatory officer, a spokesperson ...

In a report released today, Pete Osterland from Truist Financial initiated coverage with a Buy rating on TRONOX (TROX – Research Report) and a ...

Geneos Wealth Management Inc. boosted its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by 3.2% in the ...